The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change-20.2% to $47.50
Predicted High$62.00at 1 month
Predicted Low$47.50at 6 months
Max Drawdown (predicted)-20.2%
Forecast
The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded.
Predicted Aug 19, 2026 11:46 am
Bear
KMX trends lower to
$47.50
(-20.2% from $59.51)
by Feb 2027.
ride-then-fade
ThesisKMX rides risk-on momentum and 'last platform standing' narrative near-term as peer weakness lifts sentiment, but rich valuation vs $27-39 fair value range and quality/forensic red flags reassert gravity by winter, especially once a Q3 print lands inside the window.
Invalidated ifA clean earnings beat with used-vehicle unit growth reaccelerating above 5% YoY, or KMX breaking above $65 on volume, would invalidate the fade.
Checkpointtime after the call
Datewhen it gets graded
Predictedthe claim: closing price
Current priceactual close — fills in over time
Predicted returnpredicted vs $59.51 at call
Conv.brain's confidence, 1–10
Driverwhy the brain put the point here
Prediction made
Aug 19, 2026
—
$59.51at call
—
—
The anchor — every point below is measured from this price and date.
2 weeks
Sep 2, 2026
$54.04–$64.98typical range · internal point $61.20
—
±9.2%
6/10
Risk-on tape and peer-stumble narrative extend momentum
1 month
Sep 19, 2026
$51.58–$67.44typical range · internal point $62.00
—
±13.3%
5/10
Sentiment tailwind persists absent catalysts
2 months
Oct 19, 2026
$58.50
—
-1.7%
4/10
Momentum cools as valuation stretch noticed
3 months
Nov 19, 2026
$54.00
—
-9.3%
5/10
Likely Q3 print reintroduces fundamental scrutiny
4 months
Dec 19, 2026
$51.00
—
-14.3%
5/10
Value gravity toward DCF anchor accelerates
5 months
Jan 19, 2027
$49.00
—
-17.7%
6/10
Forensic concerns and quality weakness weigh
6 months
Feb 19, 2027
$47.50
—
-20.2%
6/10
Converges toward deterministic baseline endpoint
Why ranges on the short rungs?
A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here —
three prompt formulations all lost to simply predicting zero — while the stock's own
volatility scale (σ×√t) described those windows well. So the short rungs claim what's
actually knowable: the typical travel, with earnings timing flagged where the variance
will come from. The internal point calls keep being generated and graded to map where
real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.
Deterministic control (v0.3 value line) targets
$48.71
(-18.1%)
— both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it.
Brain: claude-opus-4-7.